tiprankstipranks
Trending News
More News >
MoonLake Immunotherapeutics (MLTX)
NASDAQ:MLTX
US Market

MoonLake Immunotherapeutics (MLTX) Cash flow

Compare
644 Followers

MoonLake Immunotherapeutics Cash Flow

MLTX's free cash flow for Q4 2025 was $-58.79M. For the 2025 fiscal year, MLTX's free cash flow was decreased by $-78.94M and operating cash flow was $-58.79M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -196.01M$ -116.59M$ -42.78M$ -55.89M$ -35.18M
Investing Cash Flow
$ 202.99M$ -205.60M$ -25.18M$ -32.34M$ -50.71K
Financing Cash Flow
$ 146.00M$ 51.31M$ 479.70M$ 119.69M$ 43.26M
End Cash Position
$ 334.52M$ 180.43M$ 451.17M$ 39.51M$ 8.04M
Free Cash Flow
$ -196.04M$ -117.11M$ -43.06M$ -55.91M$ -35.23M
Currency in USD

MoonLake Immunotherapeutics Cash Flow